PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 2:23 AM ET

Sponsor Check › Person

Peter Conti

Related person on Form D filings · address states as listed: MA, NJ · listed Jan 6, 2015 → Sep 15, 2020

3issuers
21Form D filings
2015–2020years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:59 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:59 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

No SEC search has run yet for this person.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:59 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

8 of 18 offerings report sales commissions totalling $710,628; 0 report finder's fees; 1 reports proceeds to related persons totalling $150,000. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Sep 15, 2020 D
File 021-375480
$0$0$0None listed on this filing
EDGAR ↗Jul 12, 2019 D
File 021-344167
$0$0$0None listed on this filing
EDGAR ↗Jun 10, 2019 D
File 021-341562
$0$0$0None listed on this filing
EDGAR ↗May 31, 2019 D
File 021-340856
$0$0$0
No payments have been proposed other than payments of salaries in the ordinary course of business.
None listed on this filing
EDGAR ↗Oct 16, 2018 D/A
File 021-315997
$0$0$0
No payments have been proposed other than payments of salaries in the ordinary course of business.
None listed on this filing
EDGAR ↗Dec 18, 2017 D
File 021-301054
$0$0$0
No payments have been proposed other than payments of salaries in the ordinary course of business.
None listed on this filing
EDGAR ↗Nov 15, 2017 D/A
File 021-289907
$0$0$0
No payments have been proposed other than payments of salaries in the ordinary course of business
None listed on this filing
EDGAR ↗Feb 6, 2017 D/A
File 021-252538
$0$0$0
No payments have been proposed other than payments of salaries in the ordinary course of business.
None listed on this filing
EDGAR ↗Apr 6, 2016 D
File 021-260742
$0$0$0None listed on this filing
EDGAR ↗Jun 8, 2015 D
File 021-241309
$28,000$0$0Merriman Capital, Inc. BrokerCheck CRD 18296 ↗
via Highline Research Advisors LLC
EDGAR ↗Jan 6, 2015 D
File 021-231528
$0$0$150,000 (est.)None listed on this filing
EDGAR ↗Jul 28, 2014 D
File 021-221871
$81,600$0$0Monarch Capital Group LLC BrokerCheck CRD 47815 ↗
EDGAR ↗Jan 10, 2014 D
File 021-209798
$69,400$0$0Monarch Capital Group LLC BrokerCheck CRD 47815 ↗
via Brookline Group LLC (CRD 153587 ↗)
EDGAR ↗Sep 27, 2013 D
File 021-203673
$33,300$0$0LifeTech Capital LLC BrokerCheck CRD 37924 ↗
Monarch Capital Group LLC BrokerCheck CRD 47815 ↗
EDGAR ↗Jul 8, 2013 D
File 021-199184
$5,250$0$0 (est.)Aurora Capital LLC BrokerCheck CRD 37924 ↗
via LifeTech Capital
EDGAR ↗Nov 21, 2012 D
File 021-187390
$123,700 (est.)$0$0Brookline Group, LLC BrokerCheck CRD 153587 ↗
EDGAR ↗Jul 7, 2011 D
File 021-162454
$141,682$0$0Noble Financial Capital Markets BrokerCheck CRD 15768 ↗
Monarch Capital Group, LLC BrokerCheck CRD 47815 ↗
Burnham Hill Partners, LLC BrokerCheck CRD 148000 ↗
EDGAR ↗Jun 1, 2011 D
File 021-160636
$227,696$0$0Burnham Hill Partners, LLC BrokerCheck CRD 148000 ↗
Monarch Capital Group, LLC BrokerCheck CRD 47815 ↗

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗AZTherapies, INCDirectorSep 15, 2020D$35,000,000
similar: $500,000–$7,000,000
$14,825,48759
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗AZTherapies, INCDirectorJul 12, 2019D$37,500,000
similar: $2,000,000–$19,999,994
$19,040,28425
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗NanoTomer, Inc.DirectorJun 10, 2019D$2,000,000
similar: $2,000,000–$14,000,000
$950,0003
similar: 1–19
$100,000
similar: $10,000–$50,000
EDGAR ↗AZTherapies, INCDirectorMay 31, 2019D$7,500,000
similar: $2,000,000–$19,999,994
$5,608,02711
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗AZTherapies, INCDirectorOct 16, 2018D/A$25,473,350
similar: $2,000,000–$19,999,994
$16,060,49135
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗AZTherapies, INCDirectorJul 3, 2018D$15,000,000
similar: $2,000,000–$19,999,994
$7,725,51225
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗AZTherapies, INCDirectorDec 18, 2017D$6,000,000
similar: $2,000,000–$19,999,994
$1,570,0009
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗AZTherapies, INCDirectorNov 15, 2017D/A$7,600,000
similar: $2,000,000–$19,999,994
$6,549,96943
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗AZTherapies, INCDirectorJun 30, 2017D$5,900,000
similar: $2,000,000–$19,999,994
$3,669,96926
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗AZTherapies, INCDirectorFeb 6, 2017D/A$20,000,000
similar: $2,000,000–$19,999,994
$16,050,23641
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗FLUOROPHARMA MEDICAL, INC.DirectorApr 6, 2016D$1,000,000
similar: $1,694,259–$16,000,000
$150,0001
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗AZTherapies, INCDirectorDec 7, 2015D$20,000,000
similar: $2,000,000–$19,999,994
$13,750,23637
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗FLUOROPHARMA MEDICAL, INC.DirectorJun 8, 2015D$2,000,000
similar: $1,694,259–$16,000,000
$350,0003
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗AZTherapies, INCDirectorJan 6, 2015D$13,000,000
similar: $1,694,259–$16,000,000
$6,110,00015
similar: 1–13
$25,000
similar: $10,000–$55,000
EDGAR ↗FLUOROPHARMA MEDICAL, INC.DirectorJul 28, 2014D$2,000,000
similar: $1,694,259–$16,000,000
$1,222,50023
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗FLUOROPHARMA MEDICAL, INC.DirectorJan 10, 2014D$2,000,000
similar: $1,694,259–$16,000,000
$877,50016
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗FLUOROPHARMA MEDICAL, INC.DirectorSep 27, 2013D$7,000,000
similar: $1,694,259–$16,000,000
$737,50011
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗FLUOROPHARMA MEDICAL, INC.DirectorJul 8, 2013D$500,000$250,0002No minimum reported
EDGAR ↗FLUOROPHARMA MEDICAL, INC.DirectorNov 21, 2012D$4,000,000$1,546,25014No minimum reported
EDGAR ↗FLUOROPHARMA MEDICAL, INC.DirectorJul 7, 2011D$6,000,000$2,355,62131No minimum reported
EDGAR ↗FLUOROPHARMA MEDICAL, INC.DirectorJun 1, 2011D$6,000,000$3,667,44231No minimum reported

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); Biotechnology / 506(b) (3,253 filings); Biotechnology / 506(c) (163 filings); Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 25 names on the same filings (0 management entities, 25 people)

People and management entities the issuers listed as related persons on the same Form D filings as Peter Conti. Source: the EDGAR rows in the table above.

  • David R. Elmaleh — 14 shared filings (3 issuers) · roles as listed: Executive Officer, Director
  • Keith Greenfield — 12 shared filings (2 issuers) · roles as listed: Director, Executive Officer · also listed on 3 other issuers
  • Ronald Tompkins — 10 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Robert Warren — 10 shared filings (2 issuers) · roles as listed: Executive Officer, Director · also listed on 15 other issuers
  • David Taft — 10 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • John Porter — 9 shared filings (1 issuer) · role as listed: Director
  • Johan (Thijs) M. Spoor — 9 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Tamara Rhein — 7 shared filings (1 issuer) · role as listed: Executive Officer
  • Walter Witoshkin — 7 shared filings (1 issuer) · role as listed: Director
  • Lawrence Atinsky — 5 shared filings (1 issuer) · role as listed: Director
  • Joseph Pierro — 5 shared filings (1 issuer) · role as listed: Director
  • Gillian Sandler — 5 shared filings (1 issuer) · role as listed: Director
  • Karen Reeves — 4 shared filings (1 issuer) · role as listed: Executive Officer
  • Brian Bartlett — 3 shared filings (2 issuers) · role as listed: Executive Officer
  • Walter Witshkin — 2 shared filings (1 issuer) · role as listed: Director
  • Andrew H. Sassine — 2 shared filings (1 issuer) · role as listed: Director
  • George T. Behrakis — 2 shared filings (1 issuer) · role as listed: Director
  • W. Austin Lewis — 1 shared filing (1 issuer) · role as listed: Director
  • Thomas H. Tulip — 1 shared filing (1 issuer) · roles as listed: Executive Officer, Director
  • Jeffrey Bell — 1 shared filing (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Jay Mohr — 1 shared filing (1 issuer) · role as listed: Executive Officer
  • Thierry Porte — 1 shared filing (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Noah Gottdiener — 1 shared filing (1 issuer) · role as listed: Director
  • Lawrence M. Atinsky — 1 shared filing (1 issuer) · role as listed: Director
  • Lawrence H. Atinsky — 1 shared filing (1 issuer) · role as listed: Director

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Peter Conti appears on a new Form D, or when a court case or SEC action is matched to them. See plans →